Drinabant is a cannabinoid receptor antagonist that was under investigation for the treatment of obesity and related metabolic disorders. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include SLV-319, drinabantum and AVE-1625. Its PubChem CID is 10278470.
Drinabant
| CAS No | 358970-97-5 |
|---|---|
| Molecular Formula | C23H20Cl2F2N2O2S |
| Molecular Weight | 497.4 g/mol |
| Synonyms | N-[1-[bis(4-chlorophenyl)methyl]azetidin-3-yl]-N-(3,5-difluorophenyl)methanesulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Drinabant is a cannabinoid receptor antagonist that was under investigation for the treatment of obesity and related metabolic disorders. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin.
The listed CAS number is 358970-97-5.
The listed molecular formula is C23H20Cl2F2N2O2S.
The listed molecular weight is 497.4 g/mol.
N-[1-[bis(4-chlorophenyl)methyl]azetidin-3-yl]-N-(3,5-difluorophenyl)methanesulfonamide.
The source lists SLV-319, drinabantum and AVE-1625.